Pontifax Late Stage GP Ltd.'s Net Worth
$0
Estimate Recalculated Nov 11, 2024 08:46AM EST
Who is Pontifax Late Stage GP Ltd.?
Pontifax Late Stage GP Ltd. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include 89bio, Inc., and Keros Therapeutics, Inc..
SEC CIK
Pontifax Late Stage GP Ltd.'s CIK is 0001793770
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Keros Therapeutics, Inc. (KROS) Snapshot price: $52.51
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.15% | -7.18K |
—
| -$0.71 | 4.63M |
Nov 29
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +1.27% | 60K |
$50.00 | $3,000,000.00 | 4.79M |
Nov 17
| |||
Form 4
| +1.27% | 60K |
$50.00 | $3,000,000.00 | 4.79M |
Nov 17
| |||
Form 4
| +1.27% | 60K |
$50.00 | $3,000,000.00 | 4.79M |
Nov 17
| |||
Form 4
| +31.88% | 3.98M |
$16.00 | $6,999,984.00 | 16.48M |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
89bio, Inc. (ETNB) Snapshot price: $8.47
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.13M |
$16.00 |
—
| 1.13M |
Nov 11 - Nov 13
| |||
| No matching records found | |||||||||